Van Leeuwen & Company LLC Invests $1.14 Million in Molina Healthcare, Inc. (NYSE:MOH)

Van Leeuwen & Company LLC purchased a new position in shares of Molina Healthcare, Inc. (NYSE:MOH - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 3,151 shares of the company's stock, valued at approximately $1,138,000.

Several other institutional investors have also recently added to or reduced their stakes in the stock. Wellington Management Group LLP lifted its holdings in Molina Healthcare by 8.3% in the 3rd quarter. Wellington Management Group LLP now owns 3,395,040 shares of the company's stock valued at $1,113,200,000 after purchasing an additional 259,474 shares in the last quarter. FMR LLC increased its holdings in Molina Healthcare by 1.0% in the third quarter. FMR LLC now owns 2,175,796 shares of the company's stock valued at $713,422,000 after buying an additional 22,583 shares during the last quarter. Invesco Ltd. lifted its stake in Molina Healthcare by 10.4% during the third quarter. Invesco Ltd. now owns 1,190,161 shares of the company's stock worth $390,242,000 after purchasing an additional 112,243 shares during the last quarter. Northern Trust Corp grew its position in shares of Molina Healthcare by 5.6% during the 3rd quarter. Northern Trust Corp now owns 604,431 shares of the company's stock valued at $198,187,000 after buying an additional 31,786 shares during the last quarter. Finally, Lord Abbett & CO. LLC boosted its position in Molina Healthcare by 28.5% during the 3rd quarter. Lord Abbett & CO. LLC now owns 470,386 shares of the company's stock valued at $154,234,000 after purchasing an additional 104,350 shares during the period. Institutional investors and hedge funds own 98.50% of the company's stock.

Analyst Upgrades and Downgrades

MOH has been the topic of a number of research reports. Bank of America downgraded Molina Healthcare from a "neutral" rating to an "underperform" rating and set a $439.00 price objective on the stock. in a research note on Thursday, March 28th. TD Cowen dropped their price target on Molina Healthcare from $453.00 to $412.00 and set a "buy" rating on the stock in a research report on Tuesday, April 30th. Barclays reduced their price objective on shares of Molina Healthcare from $437.00 to $430.00 and set an "equal weight" rating for the company in a report on Thursday, April 25th. StockNews.com cut Molina Healthcare from a "strong-buy" rating to a "buy" rating in a report on Thursday, February 8th. Finally, Stephens restated an "equal weight" rating and set a $390.00 target price on shares of Molina Healthcare in a research report on Thursday, April 25th. One analyst has rated the stock with a sell rating, four have issued a hold rating and six have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average target price of $404.90.

Insider Activity

In related news, Director Richard M. Schapiro sold 711 shares of the business's stock in a transaction that occurred on Monday, February 12th. The stock was sold at an average price of $384.06, for a total transaction of $273,066.66. Following the completion of the sale, the director now owns 12,207 shares in the company, valued at $4,688,220.42. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. In related news, Director Richard M. Schapiro sold 1,000 shares of the firm's stock in a transaction dated Tuesday, February 20th. The stock was sold at an average price of $401.05, for a total transaction of $401,050.00. Following the sale, the director now directly owns 11,207 shares in the company, valued at approximately $4,494,567.35. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Richard M. Schapiro sold 711 shares of the business's stock in a transaction on Monday, February 12th. The shares were sold at an average price of $384.06, for a total transaction of $273,066.66. Following the sale, the director now owns 12,207 shares of the company's stock, valued at approximately $4,688,220.42. The disclosure for this sale can be found here. In the last quarter, insiders have sold 16,711 shares of company stock valued at $6,472,517. 1.10% of the stock is currently owned by insiders.

Molina Healthcare Price Performance

Shares of NYSE:MOH traded up $4.57 during midday trading on Friday, reaching $354.60. 356,075 shares of the company were exchanged, compared to its average volume of 399,118. The company has a current ratio of 1.49, a quick ratio of 1.49 and a debt-to-equity ratio of 0.53. Molina Healthcare, Inc. has a one year low of $266.35 and a one year high of $423.92. The business's fifty day moving average is $379.95 and its two-hundred day moving average is $371.54. The stock has a market cap of $20.78 billion, a PE ratio of 19.24, a price-to-earnings-growth ratio of 1.04 and a beta of 0.54.

Molina Healthcare (NYSE:MOH - Get Free Report) last posted its quarterly earnings results on Wednesday, April 24th. The company reported $5.73 EPS for the quarter, topping analysts' consensus estimates of $5.46 by $0.27. Molina Healthcare had a net margin of 2.99% and a return on equity of 29.86%. The firm had revenue of $9.93 billion for the quarter, compared to analysts' expectations of $9.45 billion. During the same period in the prior year, the business posted $5.81 earnings per share. The business's revenue for the quarter was up 21.9% on a year-over-year basis. As a group, analysts predict that Molina Healthcare, Inc. will post 23.59 earnings per share for the current year.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.